Home › Research › Biomarkers
Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics
Hyemin Jang, Daeun Shin, Heejin Yoo, Henrik Zetterberg, Kaj Blennow, Fernando Gonzalez-Ortiz, Nicholas J Ashton, Theresa A Day et al.. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025-02-05
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
NfL demonstrated fair to excellent accuracy in differentiating non-ACS from CU groups (area under the curve [AUC], 0.79 to 0.94). p-tau217 had the highest accuracy for identifying Aβ (AUC 0.94) and tau positron emission tomography status (AUC 0.91). In the ACS group, p-tau217 was the strongest predictor of cognitive decline (p < .001). NfL may serve as a useful screening tool, while p-tau217 is particularly valuable for confirming AD pathology and prognosis. HIGHLIGHTS: Plasma NfL could screen for cognitive impairment. p-tau217 reliably detects AD pathology, regardless of diagnosis. p-tau217 and GFAP predict prognosis in ACS. Each plasma biomarker plays a distinct role in stepwise AD diagnostics.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jang, H., Shin, D., Yoo, H., Zetterberg, H., Blennow, K., Gonzalez-Ortiz, F., et al. (2025). Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.14526
Vancouver
Jang H, Shin D, Yoo H, Zetterberg H, Blennow K, Gonzalez-Ortiz F, et al. Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025. doi:10.1002/alz.14526. PMID: 39907189.
BibTeX
@article{jang2025-39907189,
author = {Jang, Hyemin and Shin, Daeun and Yoo, Heejin and Zetterberg, Henrik and Blennow, Kaj and Gonzalez-Ortiz, Fernando and Ashton, Nicholas J and Day, Theresa A and others},
title = {{Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics}},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
year = {2025},
doi = {10.1002/alz.14526},
pmid = {39907189},
url = {https://doi.org/10.1002/alz.14526}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- NfL demonstrated fair to excellent accuracy in differentiating non-ACS from CU groups (area under the curve [AUC], 0.79 to 0.94). p-tau217 had the highest accuracy for identifying Aβ (AUC 0.94) and tau positron emission tomography status (AUC 0.91).
- In the ACS group, p-tau217 was the strongest predictor of cognitive decline (p < .001).
- NfL may serve as a useful screening tool, while p-tau217 is particularly valuable for confirming AD pathology and prognosis.
- HIGHLIGHTS: Plasma NfL could screen for cognitive impairment. p-tau217 reliably detects AD pathology, regardless of diagnosis. p-tau217 and GFAP predict prognosis in ACS.
- Each plasma biomarker plays a distinct role in stepwise AD diagnostics.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants2,984
- Effect sizeAUC 0.94; AUC 0.91
- Evidence strengthLow
How this study scored 63/100
Published in a leading specialty journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 35 of the 56 points we could judge it on, which is 63 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Alzheimer's & dementia : the journal of the Alzheimer's Association) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 3 / 4 | 2,984 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39907189) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 35 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 35 of the 56 points we could judge it on is 63 out of 100. |
| Total | 63 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “p-tau217”
692 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 692 tagged studies.